NCT05879926 2026-03-03
OFSET
NRG Oncology
Phase 3 Recruiting
Clinical Trials
10 trialsNCT03748485 2026-01-28
CANWATCH
Sixth Affiliated Hospital, Sun Yat-sen University
Phase NA Recruiting
NCT03567889 2025-12-17
NeoDREAM
Philogen S.p.A.
Phase 3 Recruiting
NCT05595408 2025-12-09
Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma
RenJi Hospital
Recruiting
NCT06052332 2025-12-05
SHAPERS
Jules Bordet Institute
Phase NA Recruiting
NCT04567420 2025-10-16
DARE
Criterium, Inc.
Phase 2 Recruiting
NCT07067268 2025-07-16
Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy
Fudan University
Phase 2 Recruiting
NCT06914440 2025-07-15
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
Xijing Hospital
Phase 2 Recruiting
NCT06953882 2025-07-14
SELECT
Yale University
Phase 2 Recruiting
NCT06476119 2025-04-23
OPTImaL
The Netherlands Cancer Institute
Recruiting